Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, a new series of
therapeutics that correct and potentiate some classes of mutations of the CFTR, have …

Potential opportunities and challenges for infection prevent... : Current Opinion in Infectious
Diseases Potential opportunities and challenges for infection prevention and control for cystic …

Chronic respiratory infections with the gram-negative bacterium Pseudomonas aeruginosa
are an important co-morbidity for the quality of life and prognosis of people with cystic …

Objectives The impressive improvements of cystic fibrosis (CF) transmembrane conductance
regulator (CFTR) function by elexacaftor/tezacaftor/ivacaftor (ETI) result in changes in the …

Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in US cystic fibrosis
(CF) patients and is associated with worse clinical outcomes in CF. These infections often …

Abstract Pseudomonas aeruginosa (Pa) and Methicillin susceptible Staphylococcus aureus
(MSSA) are the predominant bacteria found in the airways of people with cystic fibrosis …

Background Care guidelines for cystic fibrosis (CF) have been developed to enhance
consistent care and to improve health outcomes. We determined if adherence to CF care …

Infection control in cystic fibrosis: evolving perspectives... : Current Opinion in Pulmonary
Medicine Infection control in cystic fibrosis: evolving perspectives and challenges : Current …

Background Healthcare-associated transmission of methicillin-resistant Staphylococcus
aureus (MRSA) and Pseudomonas aeruginosa occurs for people with cystic fibrosis (CF) …

Modulator therapies for people with cystic fibrosis (CF) have been transformative. But not so,
apparently, on the composition of airway microbiology [1]. Pseudomonas aeruginosa (Psa) …